Explore

Trendline Trendline
Amylyx Pharmaceuticals to Engage in Key Investor Conferences in 2026

Amylyx Pharmaceuticals to Engage in Key Investor Conferences in 2026

Amylyx Pharmaceuticals to Engage in Key Investor Conferences in 2026
Trendline Trendline
Jim Cramer's Charitable Trust Adjusts Portfolio with Goldman Sachs Sale and Johnson Johnson Purchase

Jim Cramer's Charitable Trust Adjusts Portfolio with Goldman Sachs Sale and Johnson Johnson Purchase

Jim Cramer's Charitable Trust Adjusts Portfolio with Goldman Sachs Sale and Johnson Johnson Purchase
Trendline Trendline
Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.

Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.

Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.
Trendline Trendline
Wall Street Analysts Issue Key Stock Upgrades and Downgrades Impacting Major Companies

Wall Street Analysts Issue Key Stock Upgrades and Downgrades Impacting Major Companies

Wall Street Analysts Issue Key Stock Upgrades and Downgrades Impacting Major Companies
Trendline Trendline
Stevanato Group to Participate in Three Major Investor Conferences

Stevanato Group to Participate in Three Major Investor Conferences

Stevanato Group to Participate in Three Major Investor Conferences
Trendline Trendline
Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings
Trendline Trendline
Sarepta, Amylyx, and Neumora Anticipate Key Developments Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Anticipate Key Developments Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Anticipate Key Developments Amidst Q1 Earnings
Trendline Trendline
Bristol Myers Squibb to Present at Bank of America Securities Healthcare Conference

Bristol Myers Squibb to Present at Bank of America Securities Healthcare Conference

Bristol Myers Squibb to Present at Bank of America Securities Healthcare Conference
Reuters Reuters
Novo Nordisk's weight-loss pill boom faces price war test

Novo Nordisk's weight-loss pill boom faces price war test

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN, May 5 (Reuters) - Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with U.S. rival Eli Lilly intensifies.
Trendline Trendline
Pfizer Reaffirms 2026 Guidance Amid Strong Q1 Revenue Growth

Pfizer Reaffirms 2026 Guidance Amid Strong Q1 Revenue Growth

Pfizer Reaffirms 2026 Guidance Amid Strong Q1 Revenue Growth
Trendline Trendline
BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth

BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth

BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth
Trendline Trendline
Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference